Urokinase Plasminogen Activator Surface Receptor / uPAR / CD87 (PLAUR) Antibody from ABBEXA LTD
Search, find, compare suppliers for anti-Urokinase Plasminogen Activator Surface Receptor / uPAR / CD87 (PLAUR) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Urokinase Plasminogen Activator Surface Receptor / uPAR / CD87 (PLAUR) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | Protein G purified |
| Size | 80 µl, 400 µl, |
| Concentration | n/a |
| Applications | ELISA, WB, IHC |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | The urokinase-type plasminogen activator receptor is a key molecule in the regulation of cell-surface plasminogen activation and plays an important role in many normal as well as pathologic processes. The human PLAUR cDNA encodes 335 amino acids including a predicted signal peptide of 22 residues and a hydrophobic C-terminal portion.1 It produces a highly glycosylated protein of about 50 kD in monocytes where it is anchored to the plasma membrane by glycosyl-phosphatidylinositol linkage. PLAUR, also known as UPAR, is directly associated with the carbohydrate-binding domain of SELL in the membrane of neutrophils, an association analogous to that between PLAUR and beta-2 integrins.2 PLAUR-mediated calcium mobilization is SELL dependent. UPAR mRNA levels correlate with the invasive potential of endometrial carcinomas and show a 33-fold increase in UPAR mRNA levels in advanced clinical stage endometrial tumors compared with normal endometrial tissue.3 Furthermore, the increase in UPAR mRNA levels correlated linearly with the progression of disease stage. UPAR protein expressioin correlated positively with rate of recurrence and mortality in patients with endometrial cancer.4 UPAR appears to be a useful prognostic marker for advanced endometrial cancer. |
| Immunogen | KLH-conjugated synthetic peptide between 136-166 amino acids from the Central region of human PLAUR. |
| Other Names | Cd87, Plaur, D87, UPAR, URKR, MO3, Urokinase plasminogen activator surface receptor, Monocyte activation antigen Mo3, U-PAR, Cd87, Cd87, Cd87 , Cd87 , Plaur, Plaur, Plaur , Plaur , D87, D87, D87 , D87 , UPAR, UPAR, UPAR , UPAR , URKR, URKR, URKR , URKR , MO3, MO3, MO3 , MO3 , Urokinase plasminogen activator surface receptor, Urokinase plasminogen activator surface receptor, Urokinase plasminogen activator surface receptor , Urokinase plasminogen activator surface receptor , Monocyte activation antigen Mo3, Monocyte activation antigen Mo3, Monocyte activation antigen Mo3 , Monocyte activation antigen Mo3 , U-PAR, U-PAR, U-PAR , U-PAR |
| Gene, Accession # | UniProt: Q03405 |
| Catalog # | abx033919 |
| Price | please inquire |
| Order / More Info | Urokinase Plasminogen Activator Surface Receptor / uPAR / CD87 (PLAUR) Antibody from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Antibodies